Dow Up 0.12% Nasdaq Up 1.35%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
6.23 Oct 20, 4:00PM EDT
Prev Close:6.23
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:27.67
Beta:-1.05
Next Earnings Date:10-Nov-14RPRX Earnings announcement
Day's Range:N/A - N/A
52wk Range:6.01 - 25.16
Volume:0
Avg Vol (3m):1,109,070
Market Cap:143.97M
P/E (ttm):N/A
EPS (ttm):-1.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RPRX

Comparison

Symbol% ChgMkt Cap
RPRX 0.00%143.97M
ABT62.34B
ACT59.90B
AUXL1.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback